logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

MDS/AML: MRD-guided therapy delays/prevents relapse

One-half of MRD+ patients alive and relapse-free at 1 year in RELAZA2.